New Delhi: The Delhi High Court today directedthe Drug Controller General of India to process the licenceapplication of Cipla for production and sale of genericversion of global pharma major Bayer Corporation`s liver andkidney cancer drug `Nexavar`.
Subrata Roy denied parole in Sahara case
Hamas uses donkey to attack Israeli troops
MP: Biker falls into river while crossing bridge
Don`t take us for granted, NCP warns Congress